Articles by Rowan T. Chlebowski, MD, PhD

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

Crandall, Carolyn J.; Hovey, Kathleen M.; Andrews, Christopher A.; More

Menopause. 25(1):11-20, January 2018.

  • Editorial

Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative

Drieling, Rebecca L.; LaCroix, Andrea Z.; Beresford, Shirley A.A.; More

Menopause. 23(11):1168-1175, November 2016.

  • Editorial

Dietary vitamin D and calcium intake and mammographic density in postmenopausal women

Bertone-Johnson, Elizabeth R.; Chlebowski, Rowan T.; Manson, JoAnn E.; More

Menopause. 17(6):1152-1160, November-December 2010.

Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk

Col, Nananda F.; Chlebowski, Rowan T.

Menopause. 15(4):804-809, July-August 2008.